(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Merz: 80% of Syrians in Germany should return in three years - 2Israel has clear objectives south of Litani River, but will face difficult choices further north
- 3Culinary Joys: Investigating Connoisseur Cooking at Home
- 4The Best Cell phone Brands for Tech Lovers
- 5Step by step instructions to Appropriately Keep up with Your Sunlight powered chargers for Most extreme Productivity
- Italy Brings In New Measures In 2026 To Tackle Overtourism
- Desired Travel Objections Worldwide: Where to Go Straightaway
- 4 Sound blocking Earphones for Prevalent Sound and Solace
- From Educational Loans to Obligation Free: Independence from the rat race Accomplished
- ‘Serving is not just a place’: Bayside Church Granite Bay reimagines annual mission amid conflict in Mexico
- Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- Step by step instructions to Get the Best Vehicle Rent Arrangement: Insider Tips and Systems
- 5 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- Yasser Abu Shabab's killing raises questions about Israel's militia strategy in Gaza
